Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study

D.A. Morgenstern, U. Pötschger, L. Moreno, V. Papadakis, C. Owens, S. Ash, C. Pasqualini, R. Luksch, A. Garaventa, A. Canete, M. Elliot, A. Wieczorek, G. Laureys, P. Kogner, J. Malis, E. Ruud, M. Beck-Popovic, G. Schleiermacher, D. Valteau-Couanet, R. Ladenstein

Research output: Contribution to journalArticle

Cite this

Morgenstern, D. A., Pötschger, U., Moreno, L., Papadakis, V., Owens, C., Ash, S., Pasqualini, C., Luksch, R., Garaventa, A., Canete, A., Elliot, M., Wieczorek, A., Laureys, G., Kogner, P., Malis, J., Ruud, E., Beck-Popovic, M., Schleiermacher, G., Valteau-Couanet, D., & Ladenstein, R. (2018). Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study. Pediatric Blood and Cancer, 65(11). https://doi.org/10.1002/pbc.27363